Literature DB >> 23942593

The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.

Robert E Neal1, Ryan L Smith2, Helen Kavnoudias3, Franklin Rosenfeldt4, Ruchong Ou4, Catriona A Mclean5, Rafael V Davalos6, Kenneth R Thomson3.   

Abstract

PURPOSE: Electroporation-based therapies deliver brief electric pulses into a targeted volume to destabilize cellular membranes. Nonthermal irreversible electroporation (IRE) provides focal ablation with effects dependent on the electric field distribution, which changes in heterogeneous environments. It should be determined if highly conductive metallic implants in targeted regions, such as radiotherapy brachytherapy seeds in prostate tissue, will alter treatment outcomes. Theoretical and experimental models determine the impact of prostate brachytherapy seeds on IRE treatments.
MATERIALS AND METHODS: This study delivered IRE pulses in nonanimal, as well as in ex vivo and in vivo tissue, with and in the absence of expired radiotherapy seeds. Electrical current was measured and lesion dimensions were examined macroscopically and with magnetic resonance imaging. Finite-element treatment simulations predicted the effects of brachytherapy seeds in the targeted region on electrical current, electric field, and temperature distributions.
RESULTS: There was no significant difference in electrical behavior in tissue containing a grid of expired radiotherapy seeds relative to those without seeds for nonanimal, ex vivo, and in vivo experiments (all p > 0.1). Numerical simulations predict no significant alteration of electric field or thermal effects (all p > 0.1). Histology showed cellular necrosis in the region near the electrodes and seeds within the ablation region; however, there were no seeds beyond the ablation margins.
CONCLUSION: This study suggests that electroporation therapies can be implemented in regions containing small metallic implants without significant changes to electrical and thermal effects relative to use in tissue without the implants. This supports the ability to use IRE as a salvage therapy option for brachytherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23942593     DOI: 10.1007/s00270-013-0704-1

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  10 in total

1.  The interaction between irreversible electroporation therapy (IRE) and embolization material using a validated vegetal model: an experimental study.

Authors:  Philip Chan; Catriona McLean; Stephen Chan; Gerard S Goh
Journal:  Diagn Interv Radiol       Date:  2019-07       Impact factor: 2.630

Review 2.  [Irreversible electroporation. Current value for focal treatment of prostate cancer].

Authors:  J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

Review 3.  Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.

Authors:  Nicole M Golbari; Aaron E Katz
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

Review 4.  The state of irreversible electroporation in interventional oncology.

Authors:  Mikhail Silk; David Tahour; Govindarajan Srimathveeravalli; Stephen B Solomon; Raymond H Thornton
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 5.  Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.

Authors:  J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr
Journal:  World J Urol       Date:  2016-05-04       Impact factor: 4.226

6.  Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.

Authors:  Katie S Murray; Behfar Ehdaie; John Musser; Joseph Mashni; Govindarajan Srimathveeravalli; Jeremy C Durack; Stephen B Solomon; Jonathan A Coleman
Journal:  J Urol       Date:  2016-04-23       Impact factor: 7.450

7.  Peri-tumoral Metallic Implants Reduce the Efficacy of Irreversible Electroporation for the Ablation of Colorectal Liver Metastases.

Authors:  Francois H Cornelis; Helena Cindrič; Bor Kos; Masashi Fujimori; Elena N Petre; Damijan Miklavčič; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Cardiovasc Intervent Radiol       Date:  2019-08-05       Impact factor: 2.740

8.  Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.

Authors:  Marleen C A M Melenhorst; Hester J Scheffer; Laurien G P H Vroomen; Geert Kazemier; M Petrousjka van den Tol; Martijn R Meijerink
Journal:  Cardiovasc Intervent Radiol       Date:  2015-05-21       Impact factor: 2.740

9.  The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation.

Authors:  Hester J Scheffer; Jantien A Vogel; Willemien van den Bos; Robert E Neal; Krijn P van Lienden; Marc G H Besselink; Martin J C van Gemert; Cees W M van der Geld; Martijn R Meijerink; John H Klaessens; Rudolf M Verdaasdonk
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

10.  Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate.

Authors:  Govindarajan Srimathveeravalli; Francois Cornelis; Joseph Mashni; Haruyuki Takaki; Jeremy C Durack; Stephen B Solomon; Jonathan A Coleman
Journal:  Springerplus       Date:  2016-02-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.